Review shows benefits for social responsiveness, disruptive behavior, and anxiety
Read More »HealthDay.com
Arkansas, Indiana Push to Ban Candy, Soda From SNAP Program
By I. Edwards HealthDay ReporterWEDNESDAY, April 16, 2025 (HealthDay News) — Republican governors in Arkansas and Indiana are asking the federal government for permission to ban soda and candy purchases with food stamps.Arkansas Gov. Sarah Huckabee Sanders said her goal is to improve the health of the nearly 350,000 people …
Read More »Wildfire Smoke Linked to Increased Odds of ED Visits for Mental Health
10-µg/m3 increase in wildfire-specific PM2.5 associated with higher risk for emergency visits for all-cause mental conditions, depression
Read More »FDA Approves Self-Injection of Vyvgart Hytrulo
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy
Read More »Longer Exposure to Antidepressants Increases Risk for Sudden Cardiac Death
Generally, difference in risk associated with antidepressant exposure decreases with age
Read More »American Academy of Neurology, April 5-9
By Beth Gilbert HealthDay ReporterThe annual meeting of the American Academy of Neurology was held this year from April 5 to 9 in San Diego. Participants included clinicians, academicians, allied health professionals, and others interested in neurology. The conference highlighted recent advances in neurological disorders, with presentations focusing on the diagnosis, management, …
Read More »Eviction Moratoria Reduced Child Maltreatment Rates During Pandemic
Significant reductions seen in physical abuse, sexual abuse, and neglect in association with eviction moratoria
Read More »Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
ctDNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma
Read More »Flares Occur Frequently in Generalized Pustular Psoriasis
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed
Read More »Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
By I. Edwards HealthDay ReporterTUESDAY, April 15, 2025 (HealthDay News) — Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury.The company said the injury went away after the person stopped taking the drug, called danuglipron, …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.